Fibrotic interstitial lung disease in patients with psoriasis using methotrexate: a descriptive cohort study using British Association of Dermatologists Biologics and Immunomodulator registry data
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf553 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Eleanor Clarke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Portsmouth University Hospitals NHS Trust, St Marys Hospital, Portsmouth, UK. Hauptthemen laut MEDLINE: Psoriasis, Methotrexate, Lung Diseases, Interstitial, Dermatologic Agents. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
A retrospective descriptive cohort study was performed using data from the British Association of Dermatologists Biologics and Immunomodulator Register, a registry pharmacovigilance study in the UK and Ireland looking at people with a diagnosis of psoriasis. There was no statistically significant association between methotrexate (MTX) exposure and fibrotic interstitial lung disease (fILD) occurrence. Among people exposed to MTX for psoriasis, there were 2.5 fewer fibrosis cases per 10 000 person-years compared with the nonexposed group. These findings are consistent with the evolving body of evidence challenging the perceived link between MTX exposure and development of fILD and support that chest radiography is probably unnecessary in dermatology drug monitoring clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Portsmouth University Hospitals NHS Trust, St Marys Hospital, Portsmouth, UK.
- Department of Research and Publishing, British Association of Dermatologists, London, UK.
ORCID-Profile: Eleanor Clarke, Birgitta van Bodegraven
Zitieren
APA
Clarke, E., van Bodegraven, B., & Shipman, A. R. (2025). Fibrotic interstitial lung disease in patients with psoriasis using methotrexate: a descriptive cohort study using British Association of Dermatologists Biologics and Immunomodulator registry data. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf553
Vancouver
Clarke E, van Bodegraven B, Shipman AR. Fibrotic interstitial lung disease in patients with psoriasis using methotrexate: a descriptive cohort study using British Association of Dermatologists Biologics and Immunomodulator registry data. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf553
BibTeX
@article{Clarke2025,
author = {Clarke, Eleanor and van Bodegraven, Birgitta and Shipman, Alexa R},
title = {Fibrotic interstitial lung disease in patients with psoriasis using methotrexate: a descriptive cohort study using British Association of Dermatologists Biologics and Immunomodulator registry data},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf553}
}
EUVIMED